Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
adcortyl intra-articular / intradermal 50mg/5ml suspension for injection vials
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 10mg/1ml
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
kenalog intramuscular 80mg/2ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
kenalog intramuscular 40mg/1ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
azactam 1g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 1gram
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
azactam 2g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 2gram
Israel -
inglés -
Ministry of Health
camzyos 10 mg
bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 10 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms
Israel -
inglés -
Ministry of Health
camzyos 15 mg
bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 15 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms
Israel -
inglés -
Ministry of Health
camzyos 2.5 mg
bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 2.5 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms
Israel -
inglés -
Ministry of Health
camzyos 5 mg
bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 5 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms
Israel -
inglés -
Ministry of Health
sotyktu 6 mg
bristol, myers squibb (israel) limited, israel - deucravacitinib - film coated tablets - deucravacitinib 6 mg - deucravacitinib - sotyktu is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy